Crossmark

Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

Crossref DOI link: https://doi.org/10.1038/s41591-023-02511-4

Published Online: 2023-07-28

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yin, Jun https://orcid.org/0009-0008-5428-9969
Yuan, Jingnan

Li, Yunjin

Fang, Yong

Wang, Ruoxi

Jiao, Heng

Tang, Han

Zhang, Shaoyuan

Lin, Siyun https://orcid.org/0000-0003-0218-2533
Su, Feng

Gu, Jianmin

Jiang, Tian

Lin, Dong

Huang, Zhiliang

Du, Chaoxiang

Wu, Kui https://orcid.org/0000-0002-6857-7231
Tan, Lijie https://orcid.org/0000-0003-0708-5556
Zhou, Qing https://orcid.org/0009-0003-4870-4891
License Information

Text and Data Mining valid from 2023-07-28

Version of Record valid from 2023-07-28
More Information

Article History

First Online: 28 July 2023